Carme Kinetin ingredient effective for treating signs of photodamaged skin, study finds.
This article was originally published in The Rose Sheet
Executive Summary
CARME KINETIN "ANTI-AGING" INGREDIENT ADDITIONAL TRIALS UNDER WAY with an increased number of subjects to examine the effectiveness of higher Kinetin concentrations on photodamaged and aging skin following results from a recently completed preliminary study, the Novato, Calif.-based skin care company said. A 24-week study in 90 people is evaluating the potential for "enhanced effectiveness" of Kinetin at concentrations of .01% to .1%. In addition, the preliminary trial of the plant-derived ingredient has been expanded for an additional six months to determine if the effects found in the study "are maintained or improved with continued treatment."